VBI Vaccines, Inc (VBIV) Covered Calls

You can sell covered calls on VBI Vaccines, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VBIV (prices last updated Mon 9:50 AM ET):

VBI Vaccines, Inc (VBIV) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
2.07 +0.07 2.07 2.09 90K - 0.2B
Covered Calls For VBI Vaccines, Inc (VBIV)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Apr 18 2.5 0.25 1.84 13.6% 155%
Jul 19 2.5 0.05 2.04 2.5% 7.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus. It is also developing congenital cytomegalovirus vaccine candidate for infectious disease; and therapeutic glioblastoma multiforme vaccine candidate for immuno-oncology. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.